Please refer to the following for the handling of neutralizing antibody drugs and oral drugs.

For patients who are eligible for therapeutic drugs, please check the following materials and prescribe them appropriately. In addition, please provide a detailed explanation to the patient and obtain consent before prescribing.

Neutralizing antibody drugs for novel coronavirus infections (Lonapreve (casilibimab/imdevimab), Zebudi (sotrovimab), Evasheld (tixagebimab/silgavimab)) will be owned by the government for the time being and will be provided free of charge to medical institutions, etc. doing.
If you wish to handle it, please refer to the link below.

The Tokyo metropolitan government will improve the implementation system of neutralizing antibody drug therapy for home care patients (including facilities for the elderly), reduce the number of hospitalized patients, and work to promote home-visit administration in order to control the tightness of hospital beds. I'm in. We ask for the cooperation of all medical institutions.
For details, please refer to the link below.

For the time being, oral medicines for new coronavirus infections (zocova (encitrelvir fumarate), pakilobidpack (nilmatrelvir, ritonavir)) will be owned by the government and will be managed by medical institutions and measures Free of charge at pharmacies. If you prescribe an oral therapeutic drug, you must declare the prescription record.
The oral drug (Lagebrio (molnupiravir)) has been available for general distribution since September 16, 2022.
For details, please refer to the link below.